Related Experiment Video
Updated: Aug 6, 2026
06:15
Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Recurrence of bilateral diffuse bronchiectasis after bilateral lung transplantation
Fengshi Chen1, Seiki Hasegawa, Toru Bando
1Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan.
Respirology (Carlton, Vic.)
|August 19, 2006
Summary
Bilateral diffuse bronchiectasis can recur early after lung transplantation (LT). Careful patient selection and perioperative sinusitis control are crucial for improving outcomes in these high-risk lung transplant recipients.
Area of Science:
- Pulmonology
- Transplant Surgery
- Pathology
Background:
- Bilateral diffuse bronchiectasis presents a unique challenge for lung transplantation (LT).
- Early recurrence of lung disease post-transplant can significantly impact patient prognosis.
Observation:
- Two cases of bilateral diffuse bronchiectasis are presented, both experiencing early disease recurrence after bilateral LT.
- Patient 1 underwent cadaveric LT with recurrence at 4 months, surviving 6 years.
- Patient 2 underwent living-related lobar LT with relapse at 4 months, surviving 13 months.
Findings:
- Pathological examination of explanted lungs revealed inflammatory cell infiltration in conducting airways and bronchial dilation, consistent with bilateral diffuse bronchiectasis.
- Scarcity of foamy macrophages in respiratory bronchiolar walls was a notable pathological feature.
- Similar findings were confirmed in autopsy and transbronchial biopsy specimens.
Implications:
- Lung transplantation in patients with bilateral diffuse bronchiectasis requires extreme caution.
- Perioperative management of sinusitis is strongly recommended to potentially mitigate recurrence risk.
- These findings highlight the need for refined surgical and medical strategies in managing this specific patient cohort.
Related Concept Videos
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...